1. Home
  2. TROX vs ARVN Comparison

TROX vs ARVN Comparison

Compare TROX & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$4.92

Market Cap

680.2M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$11.82

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
ARVN
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.2M
781.0M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
TROX
ARVN
Price
$4.92
$11.82
Analyst Decision
Hold
Buy
Analyst Count
8
23
Target Price
$4.69
$17.89
AVG Volume (30 Days)
4.9M
872.3K
Earning Date
02-11-2026
02-10-2026
Dividend Yield
4.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,844,000,000.00
$312,300,000.00
Revenue This Year
N/A
$11.17
Revenue Next Year
$3.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
93.86
52 Week Low
$2.86
$5.90
52 Week High
$10.60
$20.90

Technical Indicators

Market Signals
Indicator
TROX
ARVN
Relative Strength Index (RSI) 68.68 49.67
Support Level $4.08 $11.01
Resistance Level $4.30 $12.00
Average True Range (ATR) 0.21 0.54
MACD 0.01 -0.13
Stochastic Oscillator 93.86 44.09

Price Performance

Historical Comparison
TROX
ARVN

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: